Close Menu
Advertisement
Subscribe
[the_ad id="32629"]
Acute Lymphoblastic Leukemia

Statistical Considerations in RCC: Biomarker-Based Studies

Editor By No Comments1 Min Read

Meredith M. Regan, ScD of the Dana-Farber Cancer Institute presents “Statistical Considerations in RCC: Biomarker-Based Studies” at the 14th International Kidney Cancer Symposium.

Share.

Related Posts